Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adult Stem Cell Therapeutics in Diabetic Retinopathy
Sriprachodaya Gaddam, Ramesh Periasamy, Rajashekhar Gangaraju
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 19, pp. 4876-4876
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Early Biomarkers of Neurodegenerative and Neurovascular Disorders in Diabetes
Aleksandra Gąsecka, Dominika Siwik, Magdalena Gajewska, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 9, pp. 2807-2807
Open Access | Times Cited: 87
Bone marrow mesenchymal stem cells-induced exosomal microRNA-486-3p protects against diabetic retinopathy through TLR4/NF-κB axis repression
W. Li, Longyu Jin, Yue Cui, et al.
Journal of Endocrinological Investigation (2020) Vol. 44, Iss. 6, pp. 1193-1207
Closed Access | Times Cited: 77
Diabetic Retinopathy: New Treatment Approaches Targeting Redox and Immune Mechanisms
Qi Tang, Francesco Buonfiglio, Elsa Wilma Böhm, et al.
Antioxidants (2024) Vol. 13, Iss. 5, pp. 594-594
Open Access | Times Cited: 13
Global trends and performances in diabetic retinopathy studies: A bibliometric analysis
Huan Xiao, Jinfan Tang, Feng Zhang, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 20
Loss of Angiotensin-Converting Enzyme 2 Exacerbates Diabetic Retinopathy by Promoting Bone Marrow Dysfunction
Yaqian Duan, Eleni Beli, Sergio Li Calzi, et al.
Stem Cells (2018) Vol. 36, Iss. 9, pp. 1430-1440
Open Access | Times Cited: 52
Exosomes and Obesity-Related Insulin Resistance
Li-Min Lei, Xiao Lin, Feng Xu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 34
Neuroprotective effect of mesenchymal stem cell-derived extracellular vesicles on optic nerve injury in chronic ocular hypertension
Fei Yu, Yao Wang, Changquan Huang, et al.
Neural Regeneration Research (2023) Vol. 18, Iss. 10, pp. 2301-2301
Open Access | Times Cited: 14
Insights into stem cell therapy for diabetic retinopathy: a bibliometric and visual analysis
Ying Leng, Xiangjun Li, Chunyan Li, et al.
Neural Regeneration Research (2020) Vol. 16, Iss. 1, pp. 172-172
Open Access | Times Cited: 38
Changing landscape of anti-angiogenic therapy: Novel approaches and clinical perspectives
Rajesh N. Gacche
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 189020-189020
Closed Access | Times Cited: 11
The importance of stem cells in the treatment of type 1 diabetes, type 2 diabetes and diabetes complications
Monika Kamińska, Maria Jasiewicz, Magdalena Miernik-Skrzypczak, et al.
Quality in Sport (2025) Vol. 37, pp. 57420-57420
Open Access
Programmed cell death in stem cell-based therapy: Mechanisms and clinical applications
Xi‐min Hu, Qí Zhāng, Rui-Xin Zhou, et al.
World Journal of Stem Cells (2021) Vol. 13, Iss. 5, pp. 386-415
Open Access | Times Cited: 27
Recent Advances in Hydrogels: Ophthalmic Applications in Cell Delivery, Vitreous Substitutes, and Ocular Adhesives
Kenny T. Lin, Athena Wang, Alexandra B. Nguyen, et al.
Biomedicines (2021) Vol. 9, Iss. 9, pp. 1203-1203
Open Access | Times Cited: 26
Current Status of Mesenchymal Stem/Stromal Cells for Treatment of Neurological Diseases
Milena Botelho Pereira Soares, Renata Guedes de Jesus Gonçalves, Juliana Ferreira Vasques, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 18
Advances in cell therapies using stem cells/progenitors as a novel approach for neurovascular repair of the diabetic retina
Judith Lechner, Reinhold J. Medina, Noemi Lois, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Cell‐based therapy for diabetic cardiovascular complications: Prospects and challenges
Jia‐Peng Li, M.S. FU, Xiao‐Xue Li, et al.
British Journal of Pharmacology (2024)
Closed Access | Times Cited: 3
Stem cell therapy in ocular pathologies in the past 20 years
Giovanni Miotti, Pier Camillo Parodi, Marco Zeppieri
World Journal of Stem Cells (2021) Vol. 13, Iss. 5, pp. 366-385
Open Access | Times Cited: 23
Preventive Effects of Exosome-Rich Conditioned Medium From Amniotic Membrane-Derived Mesenchymal Stem Cells for Diabetic Retinopathy in Rats
Hyemin Kim, Yeong-Seok Goh, Sang-Eun Park, et al.
Translational Vision Science & Technology (2023) Vol. 12, Iss. 8, pp. 18-18
Open Access | Times Cited: 8
Mesenchymal Stem Cell Induced Foxp3(+) Tregs Suppress Effector T Cells and Protect against Retinal Ischemic Injury
Mona Agrawal, Pratheepa Kumari Rasiah, Amandeep Bajwa, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 3006-3006
Open Access | Times Cited: 20
Modulation of Mesenchymal Stem Cells for Enhanced Therapeutic Utility in Ischemic Vascular Diseases
Sally L. Elshaer, Salma H. Bahram, Pranav Rajashekar, et al.
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 249-249
Open Access | Times Cited: 20
Mesenchymal-Stem-Cell-Based Strategies for Retinal Diseases
Xiteng Chen, Yuanfeng Jiang, Yanan Duan, et al.
Genes (2022) Vol. 13, Iss. 10, pp. 1901-1901
Open Access | Times Cited: 14
Recent Advancements in the Medical Treatment of Diabetic Retinal Disease
M Szymańska, Daanyaal Mahmood, Timothy E. Yap, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9441-9441
Open Access | Times Cited: 17
The Fate Status of Stem Cells in Diabetes and its Role in the Occurrence of Diabetic Complications
Jinyi Xu, Chengguo Zuo
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 17
Clinical-grade human embryonic stem cell–derived mesenchymal stromal cells ameliorate diabetic retinopathy in db/db mice
Liyuan Rong, Wumei Wei, Yifan Fang, et al.
Cytotherapy (2024) Vol. 26, Iss. 6, pp. 606-615
Open Access | Times Cited: 2
Gradient Conducting Polymer Surfaces with Netrin-1-conjugation Promote Axon Guidance and Neuron Transmission of Human iPSC-derived Retinal Ganglion Cells
Jia-Wei She, C.S. Young, Shih‐Jie Chou, et al.
Biomaterials (2024) Vol. 313, pp. 122770-122770
Closed Access | Times Cited: 2
Stem cell-based therapies for retinal diseases: focus on clinical trials and future prospects
Sagnik Sen, Thales A. C. de Guimarães, Aluisio Rosa Gameiro Filho, et al.
Ophthalmic Genetics (2024), pp. 1-14
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top